KUALA LUMPUR, Jan 28 -- Soka Gakkai International (SGI) Buddhist network president, Daisaku Ikeda recently released the 38th annual peace proposal to mark the anniversary of the SGI founding.
The main theme of the proposal, ‘Toward Our Shared Future: Constructing an Era of Human Solidarity’, was on climate action and nuclear weapon abolition, with focus on the individual lives and suffering often hidden behind macroeconomic indices.
Ikeda describes climate change as ‘a fundamental challenge, on which the fate of humankind hinges’ and stresses it threatens to render meaningless, global efforts toward achieving Sustainable Development Goals.
Praising the energy of youth climate activists, he said: “When young people's will to transform reality merges with an indomitable optimism, the possibilities are limitless.”
Ikeda proposes that UN Youth Climate Summits be held every year toward 2030 and calls for a Security Council Resolution mainstreaming youth participation in climate-related decision-making.
He also proposes holding a People's Forum for a World Without Nuclear Weapons centered on hibakusha and civil society in Hiroshima or Nagasaki to follow the treaty's entry into force.
Ikeda also highlights the plight of children and youth deprived of educational opportunities due to armed conflict or natural disasters, and therefore calls for strengthening of the financial foundation of the UNICEF-hosted Education Cannot Wait global fund.
He concludes with a commitment to continued grassroots action, saying: The SGI will further promote empowerment of, by and for the people, as we address the climate crisis and other challenges with an expanding movement of global solidarity.”
SGI is a community-based Buddhist network promoting peace, culture and education with 12 million members. More details at https://www.sgi.org.
-- BERNAMA
Thursday, January 30, 2020
Wednesday, January 29, 2020
FERRING'S PROPESS® IS THE FIRST PHARMACOLOGICAL TREATMENT FOR CERVICAL RIPENING TO BE APPROVED IN JAPAN FOR OVER 20 YEARS
· Ferring announces that the Minister of Health, Labour and Welfare (MHLW) in Japan has approved Propess® (dinoprostone) for the initiation of cervical ripening1
View source version on businesswire.com:
https://www.businesswire.com/news/home/20200122005902/en/
Contact
Bhavin Vaid
Head of Corporate Communications
+41 58 301 0952 (direct)
+41 79 191 0632 (mobile)
bhavin.vaid@ferring.com
Lindsey Rodger
Senior Manager, Corporate Communications
+41 58 451 4023 (direct)
+41 79 191 0486 (mobile)
lindsey.rodger@ferring.com
Source : Ferring Pharmaceuticals
--BERNAMA
· Propess, developed in Scotland, UK, and marketed in over 60 countries, was approved following close collaboration with the patient community in Japan
· This approval provides women in Japan with greater choice and is part of Ferring’s commitment to advancing Reproductive Medicine and Maternal Health worldwide
· This approval provides women in Japan with greater choice and is part of Ferring’s commitment to advancing Reproductive Medicine and Maternal Health worldwide
SAINT-PREX, Switzerland, Jan 23 (Bernama-BUSINESS WIRE) -- Ferring Pharmaceuticals today announced that Propess® (dinoprostone) has been approved by the Minister of Health, Labour and Welfare (MHLW) in Japan for initiation of cervical ripening in patients at term (from 37 completed weeks of gestation).1 This is the first time in over 20 years that a pharmacological therapy for cervical ripening has been approved in the country.2
Around 10 per cent of births globally require induction of labour, which may be required if the health of the mother or baby is at risk.3,4 Cervical ripening is carried out prior to induction to prepare the cervix for birth. This approval offers women requiring an induction in Japan greater choice of alternatives to mechanical methods of cervical ripening.
“The approval of Propess in Japan is a big step forward in offering women more choice when it comes to cervical ripening,” said Per Falk, President and Chief Science Officer, Ferring Pharmaceuticals. “There is a lack of research and development of treatment options for women who are pregnant or giving birth, which is why it is important for Ferring to continue to invest and advance the field of Reproductive Medicine and Maternal Health and continue with our purpose of building families worldwide.”
The announcement today follows a close collaboration between Ferring Pharmaceuticals and a local patient advocacy group to ensure the needs and safety of women in labour are addressed in Japan.
“For women giving birth, mechanical methods may not always be the right option and it is important that a woman’s safety and comfort is paramount,” said Mikiya Kitamura, Vice President, Ferring Japan R&D. “Ensuring that a treatment is safe and effective is a priority for us, and we are pleased to have been able to work together with our local patient advocacy group on this significant milestone.”
Propess is currently marketed in over 60 countries and was developed in the 1980s in Scotland where it continues to be manufactured. As leaders in Reproductive Medicine and Maternal Health, this approval demonstrates Ferring’s continued commitment to helping people around the world to build healthy families.
About Propess5
Propess is a vaginal delivery system containing the active substance dinoprostone 10 mg used for the initiation of cervical ripening in women at term (from 37 completed weeks of gestation). The dinoprostone softens and opens the part of the birth canal known as the cervix, to start the process of labour.
About labour6
Labour is initiated or induced by obstetricians in situations where it is considered safer, for the mother or the unborn child, to be delivered. This could be due to pre-eclampsia (sudden, severe rise in blood pressure and kidney impairment), poor growth in the baby, unexplained bleeding in the last phase of pregnancy or a prolonged pregnancy (the most common reason). The success of induction of labour is related to the condition of the cervix prior to the induction. If during examination of the cervix length, positioning and softening, it is deemed unfavourable, then cervical ripening will be initiated.
About Ferring Pharmaceuticals
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build healthy families and live better lives. Headquartered in Saint-Prex, Switzerland, Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years and has a portfolio covering treatments from conception to birth. Founded in 1950, privately-owned Ferring now employs approximately 6,500 people worldwide, has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.
Learn more at www.ferring.com, or connect with us on Twitter, Facebook, Instagram, LinkedIn and YouTube.
References
Around 10 per cent of births globally require induction of labour, which may be required if the health of the mother or baby is at risk.3,4 Cervical ripening is carried out prior to induction to prepare the cervix for birth. This approval offers women requiring an induction in Japan greater choice of alternatives to mechanical methods of cervical ripening.
“The approval of Propess in Japan is a big step forward in offering women more choice when it comes to cervical ripening,” said Per Falk, President and Chief Science Officer, Ferring Pharmaceuticals. “There is a lack of research and development of treatment options for women who are pregnant or giving birth, which is why it is important for Ferring to continue to invest and advance the field of Reproductive Medicine and Maternal Health and continue with our purpose of building families worldwide.”
The announcement today follows a close collaboration between Ferring Pharmaceuticals and a local patient advocacy group to ensure the needs and safety of women in labour are addressed in Japan.
“For women giving birth, mechanical methods may not always be the right option and it is important that a woman’s safety and comfort is paramount,” said Mikiya Kitamura, Vice President, Ferring Japan R&D. “Ensuring that a treatment is safe and effective is a priority for us, and we are pleased to have been able to work together with our local patient advocacy group on this significant milestone.”
Propess is currently marketed in over 60 countries and was developed in the 1980s in Scotland where it continues to be manufactured. As leaders in Reproductive Medicine and Maternal Health, this approval demonstrates Ferring’s continued commitment to helping people around the world to build healthy families.
About Propess5
Propess is a vaginal delivery system containing the active substance dinoprostone 10 mg used for the initiation of cervical ripening in women at term (from 37 completed weeks of gestation). The dinoprostone softens and opens the part of the birth canal known as the cervix, to start the process of labour.
About labour6
Labour is initiated or induced by obstetricians in situations where it is considered safer, for the mother or the unborn child, to be delivered. This could be due to pre-eclampsia (sudden, severe rise in blood pressure and kidney impairment), poor growth in the baby, unexplained bleeding in the last phase of pregnancy or a prolonged pregnancy (the most common reason). The success of induction of labour is related to the condition of the cervix prior to the induction. If during examination of the cervix length, positioning and softening, it is deemed unfavourable, then cervical ripening will be initiated.
About Ferring Pharmaceuticals
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build healthy families and live better lives. Headquartered in Saint-Prex, Switzerland, Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years and has a portfolio covering treatments from conception to birth. Founded in 1950, privately-owned Ferring now employs approximately 6,500 people worldwide, has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.
Learn more at www.ferring.com, or connect with us on Twitter, Facebook, Instagram, LinkedIn and YouTube.
References
1 Minister of Health, Labour and Welfare (MHLW). Approval of Propess (dinoprostone). January 2020. Japan New Drug Application (NDA) approval document.
2 Ferring Pharmaceuticals. Data on file. January 2020.
3 World Health Organization. WHO Recommendations for Induction of Labour. Geneva: World Health Organization; 2011. Available at:
https://www.who.int/reproductivehealth/publications/
maternal_perinatal_health/9789241501156/en/ Last accessed: January 2020.
4 The American College of Obstetricians and Gynecologists. Frequently asked questions: Labor delivery and postpartum care. Available at:
https://www.acog.org/Patients/FAQs/Labor-Induction?IsMobileSet=false
Last accessed: January 2020.
5 Propess summary of product characteristics (SmPC). Available at:
https://www.medicines.org.uk/emc/product/135/smpc.
Last accessed: January 2020.
6 World Health Organization. Managing complications in pregnancy and childbirth: a guide for midwives and doctors – 2nd ed. Geneva: World Health Organization; 2017.Available at:
https://www.who.int/maternal_child_adolescent/documents/
managing-complications-pregnancy-childbirth/en/. Last accessed: January 2020
2 Ferring Pharmaceuticals. Data on file. January 2020.
3 World Health Organization. WHO Recommendations for Induction of Labour. Geneva: World Health Organization; 2011. Available at:
https://www.who.int/reproductivehealth/publications/
maternal_perinatal_health/9789241501156/en/ Last accessed: January 2020.
4 The American College of Obstetricians and Gynecologists. Frequently asked questions: Labor delivery and postpartum care. Available at:
https://www.acog.org/Patients/FAQs/Labor-Induction?IsMobileSet=false
Last accessed: January 2020.
5 Propess summary of product characteristics (SmPC). Available at:
https://www.medicines.org.uk/emc/product/135/smpc.
Last accessed: January 2020.
6 World Health Organization. Managing complications in pregnancy and childbirth: a guide for midwives and doctors – 2nd ed. Geneva: World Health Organization; 2017.Available at:
https://www.who.int/maternal_child_adolescent/documents/
managing-complications-pregnancy-childbirth/en/. Last accessed: January 2020
View source version on businesswire.com:
https://www.businesswire.com/news/home/20200122005902/en/
Contact
Bhavin Vaid
Head of Corporate Communications
+41 58 301 0952 (direct)
+41 79 191 0632 (mobile)
bhavin.vaid@ferring.com
Lindsey Rodger
Senior Manager, Corporate Communications
+41 58 451 4023 (direct)
+41 79 191 0486 (mobile)
lindsey.rodger@ferring.com
Source : Ferring Pharmaceuticals
--BERNAMA
Friday, January 24, 2020
Evercore recognised Best M&A Adviser in Singapore by The Asset magazine
KUALA LUMPUR, Jan 20 -- Evercore, the leading global independent investment banking advisory firm, has once again been recognised Best M&A Adviser in Singapore by The Asset magazine at its 2019 Triple A Country Awards ceremony in Hong Kong recently.
The annual awards, now in its 21st year, is Asia’s pre-eminent recognition for best-in-class institutions operating within the region, according to a statement.
Evercore has received this award in four of the five years since 2015, the first full year that Evercore obtained its Capital Markets Services licence from the Monetary Authority of Singapore.
Since its establishment, Evercore has advised on some of the largest, most complex and transformational transactions in Singapore, one of the world’s largest financial centres.
“I am extremely proud of the growth of our Singapore business in the past five years and of the advice that we have provided to the largest corporates, government-linked institutions, prominent families, financial sponsors and businesses within the region,” said Evercore president and chief executive officer, Ralph Schlosstein.
“We are confident that Evercore Singapore will remain a core pillar of the Firm, given its success and Singapore’s position as a key strategic hub for Asia.”
Evercore provides conflict-free, expert advice to clients regarding the execution of key strategic initiatives, including cross-border transactions and the deployment of strategic capital.
More details at www.evercore.com.
-- BERNAMA
The annual awards, now in its 21st year, is Asia’s pre-eminent recognition for best-in-class institutions operating within the region, according to a statement.
Evercore has received this award in four of the five years since 2015, the first full year that Evercore obtained its Capital Markets Services licence from the Monetary Authority of Singapore.
Since its establishment, Evercore has advised on some of the largest, most complex and transformational transactions in Singapore, one of the world’s largest financial centres.
“I am extremely proud of the growth of our Singapore business in the past five years and of the advice that we have provided to the largest corporates, government-linked institutions, prominent families, financial sponsors and businesses within the region,” said Evercore president and chief executive officer, Ralph Schlosstein.
“We are confident that Evercore Singapore will remain a core pillar of the Firm, given its success and Singapore’s position as a key strategic hub for Asia.”
Evercore provides conflict-free, expert advice to clients regarding the execution of key strategic initiatives, including cross-border transactions and the deployment of strategic capital.
More details at www.evercore.com.
-- BERNAMA
Thursday, January 23, 2020
Nippon Express consolidates 3 group companies in Italy
KUALA LUMPUR, Jan 17 -- Three Nippon Express Group companies in Italy, namely Nippon Express Italia Srl, Franco Vago SpA and Traconf Srl were merged to form Nippon Express Italia SpA on Jan 1.
The merger aims to accelerate and maximise synergy in sales and operations in one fell swoop and achieve dramatic growth, inclusive of existing Nippon Express Italia Srl, to step up efforts in the high-fashion sector.
According to a statement, it also aims to make the new company a leading provider of logistics services to the fashion logistics sector.
The merger also makes Nippon Express Italia SpA the largest Nippon Express Group company in Europe and the second largest overseas subsidiary after Nippon Express USA Inc.
The merger will also result in a new Lifestyle Division to go beyond high fashion to target lifestyle, enhance rate competitiveness via joint sorting/collection/co-loading in forwarding and trucking operations as well as extended lifestyle business model from Italy to the rest of the Nippon Express network.
More details at http://www.nipponexpress.com/
-- BERNAMA
The merger aims to accelerate and maximise synergy in sales and operations in one fell swoop and achieve dramatic growth, inclusive of existing Nippon Express Italia Srl, to step up efforts in the high-fashion sector.
According to a statement, it also aims to make the new company a leading provider of logistics services to the fashion logistics sector.
The merger also makes Nippon Express Italia SpA the largest Nippon Express Group company in Europe and the second largest overseas subsidiary after Nippon Express USA Inc.
The merger will also result in a new Lifestyle Division to go beyond high fashion to target lifestyle, enhance rate competitiveness via joint sorting/collection/co-loading in forwarding and trucking operations as well as extended lifestyle business model from Italy to the rest of the Nippon Express network.
More details at http://www.nipponexpress.com/
-- BERNAMA
Tuesday, January 21, 2020
Japanese service, 2 Malaysian brands join forces to create co-working, co-living space
KUALA LUMPUR, Jan 20 -- KabuK Style Co Ltd (Japan) has announced cooperation with Malaysia-based brands, Apple Vacation group and Le Apple Boutique Hotel, to create co-working and co-living space, beginning Jan 1.
These companies hope to boost these local activities and bring benefits inside and outside the countries, according to a statement.
Recently, HafH which operates the co-living, co-working space in Japan has been expanded to Europe and America. By collaborating facilities in Le Apple Boutique Hotel and HafH system, these companies hope to establish a new branch in Malaysia.
In addition, HafH has been developing the linked facilities in Kuala Lumpur, directly managing the facilities with other cities including Melaka, Ipoh, Penang and Kota Kinabalu. Through this collaboration, KabuK hopes to boost the expansion towards Asia and the world.
It takes three minutes to walk from the shopping centre in Kuala Lumpur to this branch. The company is about to look for premises in March, this year.
In the future, it will extend branches comprehensively in Malaysia by using Le Apple Boutique Hotel’s available facilities and HafH partners’ facilities in 15 other countries.
More details at https://kabuk.com and https://hafh.com.
-- BERNAMA
These companies hope to boost these local activities and bring benefits inside and outside the countries, according to a statement.
Recently, HafH which operates the co-living, co-working space in Japan has been expanded to Europe and America. By collaborating facilities in Le Apple Boutique Hotel and HafH system, these companies hope to establish a new branch in Malaysia.
In addition, HafH has been developing the linked facilities in Kuala Lumpur, directly managing the facilities with other cities including Melaka, Ipoh, Penang and Kota Kinabalu. Through this collaboration, KabuK hopes to boost the expansion towards Asia and the world.
It takes three minutes to walk from the shopping centre in Kuala Lumpur to this branch. The company is about to look for premises in March, this year.
In the future, it will extend branches comprehensively in Malaysia by using Le Apple Boutique Hotel’s available facilities and HafH partners’ facilities in 15 other countries.
More details at https://kabuk.com and https://hafh.com.
-- BERNAMA
Monday, January 20, 2020
´Beyond Human´ tops global consumer trends - Euromonitor International
KUALA LUMPUR, Jan 15 -- Beyond Human, which embraces artificial intelligence for automation and convenience, has topped the global consumer trends in 2020, according to Euromonitor International.
The global market research company recently released a report on the ‘Top 10 Global Consumer Trends 2020’, identifying the most influential trends shaping consumer behaviour, shopping habits and purchasing decisions.
Coming second in consumer preference is Catch Me in Seconds, seeking quick, concise and multisensory content for instant gratification, followed by Frictionless Mobility, choosing transportation methods based on individual preferences for a seamless travel journey.
Other trends are Inclusive for All; Minding Myself; Multifunctional Homes; Private Personalisation; Proudly Local, Going Global; Reuse Revolutionaries; and, We Want Clean Air Everywhere.
“Convenience and personal control are the core themes connecting these trends in 2020. Consumers are putting themselves first as they look for ways to simplify their lives,” said Euromonitor International consumer trends director, Gina Westbrook.
-- BERNAMA
The global market research company recently released a report on the ‘Top 10 Global Consumer Trends 2020’, identifying the most influential trends shaping consumer behaviour, shopping habits and purchasing decisions.
Coming second in consumer preference is Catch Me in Seconds, seeking quick, concise and multisensory content for instant gratification, followed by Frictionless Mobility, choosing transportation methods based on individual preferences for a seamless travel journey.
Other trends are Inclusive for All; Minding Myself; Multifunctional Homes; Private Personalisation; Proudly Local, Going Global; Reuse Revolutionaries; and, We Want Clean Air Everywhere.
“Convenience and personal control are the core themes connecting these trends in 2020. Consumers are putting themselves first as they look for ways to simplify their lives,” said Euromonitor International consumer trends director, Gina Westbrook.
-- BERNAMA
GraysOnline hosts mega online bushfire auction, beginning Feb 1
KUALA LUMPUR, Jan 13 -- Come Feb 1, GraysOnline will host a week-long mega online bushfire auction, giving Australians the opportunity to turn their valuable items into much-needed funds for bushfire relief.
The ongoing bushfire catastrophe engulfing much of south-east Australia has stretched firefighting and animal rescue groups to breaking point. GraysOnline is launching the event to raise much-needed funds for volunteer firefighters and animal welfare.
“Like all Australians, the team at GraysOnline has watched in horror at the devastation caused during the current bushfire crisis,” said GraysOnline managing director, Chris Corbin.
“The team decided to use our auction platform and expertise to launch this major online auction event to raise funds for the people at the front line who are working tirelessly to protect people, homes and animals.”
The company is calling on Australians to donate their valuable or unused items for the major auction, whereby 100 per cent of auction proceeds will go to bushfire relief, according to a statement.
GraysOnline will provide all listings, shipping, marketing and logistics on their leading online auction platform for free.
This one-off mega auction gives individuals and businesses all over Australia the opportunity to join the fund-raising effort supporting important organisations in their efforts to protect people, property and wildlife.
Donations of items for the auction can be made at www.graysonline.com/charityauction. Hundred per cent of the proceeds will be shared equally between NSW RFS, VIC CFA and WIRES.
-- BERNAMA
Subscribe to:
Posts (Atom)